TITLE

Arsenic trioxide induces regulated, death receptor-independent cell death through a Bcl-2-controlled pathway

AUTHOR(S)
Scholz, Christian; Richter, Antje; Lehmann, Mario; Schulze-Osthoff, Klaus; Dörken, Bernd; Daniel, Peter T.
PUB. DATE
October 2005
SOURCE
Oncogene;10/27/2005, Vol. 24 Issue 47, p7031
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Arsenic trioxide (As2O3, arsenite) efficiently kills cells from various hematologic malignancies and has successfully been employed especially for the treatment of acute promyelocytic leukemia. There and in lymphoid cells, we demonstrated that As2O3 induces cell death in a caspase-2- and -9-independent fashion. Here, we address a potential role of death receptor signaling through the FADD/caspase-8 death-inducing signaling complex in As2O3-induced cell death. In detail, we demonstrate that As2O3 induces cell death independently of caspase-8 or FADD and cannot be blocked by disruption of CD95/Fas receptor ligand interaction. Unlike in death receptor ligation-induced apoptosis, As2O3-induced cell death was not blocked by the broad-spectrum caspase inhibitor z-VAD-fmk or the caspase-8-specific inhibitor z-IETD-fmk. Nevertheless, As2O3-induced cell death occurred in a regulated manner and was abrogated upon Bcl-2 overexpression. In contrast, As2O3-induced cell demise was neither blocked by the caspase-9 inhibitor z-LEHD-fmk nor substantially inhibited through the expression of a dominant negative caspase-9 mutant. Altogether our data demonstrate that As2O3-induced cell death occurs independently of the extrinsic death receptor pathway of apoptosis. Cell death proceeds entirely via an intrinsic, Bcl-2-controlled mitochondrial pathway that does, however, not rely on caspase-9.Oncogene (2005) 24, 7031–7042. doi:10.1038/sj.onc.1208868; published online 11 July 2005
ACCESSION #
18668721

 

Related Articles

  • A critical role of glutathione in determining apoptosis sensitivity and resistance in leukemia cells. Friesen, C.; Kiess, Y.; Debatin, K.-M. // Cell Death & Differentiation;Jul2004 Supplement 1, Vol. 11, pS73 

    In chemosensitive leukemias and solid tumors, anticancer drugs have been shown to induce apoptosis. Deficiencies in the apoptotic pathways may lead to chemoresistance. Here we report that glutathione (GSH) plays a critical role in activation of apoptosis pathways by CD95 (APO-1/Fas) or...

  • Small Molecule Inhibitors of Stat3 Signaling Pathway. Jinxia Deng; Grande, Fedora; Neamati, Nouri // Current Cancer Drug Targets;Feb2007, Vol. 7 Issue 1, p91 

    Constitutive activation of the Signal Transducers and Activators of Transcription 3 (Stat3) meditated signaling pathway is very important for cell growth and survival. Compelling evidence from mechanistic studies with antisense, RNA interference (RNAi), peptides, and small molecular inhibitors...

  • Macroautophagy as a Target of Cancer Therapy. Lorin, S�verine; Codogno, Patrice; Djavaheri-Mergny, Mojgan // Current Cancer Therapy Reviews;2007, Vol. 3 Issue 3, p199 

    Macroautophagy (hereafter referred as to autophagy) is a vacuolar lysosomal degradative pathway for cytoplasmic macromolecules and organelles. There is growing evidence that autophagy is controlled by tumor-regulating molecules, and that it is downregulated during the early stages of...

  • Enhanced Therapeutic Efficacy by Simultaneously Targeting Two Genetic Defects in Tumors. He Zhang; Haibo Wang; Jianjun Zhang; Guanxiang Qian; Beibei Niu; Xianqun Fan; Jian Lu; Hoffman, Andrew R.; Ji-Fan Hu; Shengfang Ge // Molecular Therapy;Jan2009, Vol. 17 Issue 1, p57 

    Targeting tumor-specific gene abnormalities has become an attractive approach in developing therapeutics to treat cancer. Overexpression of Bcl2 and mutations of p53 represent two of the most common molecular defects in tumors. In the nucleus, p53 induces cell cycle arrest, while it interacts...

  • Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy. Richardson, Alan; Kaye, Stanley B. // Current Molecular Pharmacology;Nov2008, Vol. 1 Issue 3, p244 

    Conventional chemotherapy for cancer utilizes cytotoxic agents which elicit their therapeutic effect in part through the induction of apoptosis. In contrast, drugs which have been developed more recently and which are referred to as "targeted therapy" may exhibit less unwanted toxicity but in...

  • A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. Mellor, H. R.; Ferguson, D. J. P.; Callaghan, R. // British Journal of Cancer;8/8/2005, Vol. 93 Issue 3, p302 

    The quiescent cell population of tumours poses a barrier to the success of many cancer therapies. Most chemotherapeutic drugs target proliferating cells, but the growth fraction of many tumours is low. Based on the multicellular tumour spheroid model, a system was developed using human colon...

  • Current status of the molecular mechanisms of anticancer drug-induced apoptosis: The contribution of molecular-level analysis to cancer chemotherapy. Kim, Ryungsa; Tanabe, Kazuaki; Uchida, Yoko; Emi, Manabu; Inoue, Hideki; Toge, Tetsuya // Cancer Chemotherapy & Pharmacology;Nov2002, Vol. 50 Issue 5, p343 

    Apoptosis is an important phenomenon in cytotoxicity induced by anticancer drugs. Here, we review the current status of the molecular mechanisms of anticancer drug-induced apoptosis in order to assess the contribution of molecular-level analysis to cancer chemotherapy. It is apparent that the...

  • Promoting apoptosis as a strategy for cancer drug discovery. Fesik, Stephen W. // Nature Reviews Cancer;Nov2005, Vol. 5 Issue 11, p876 

    Apoptosis is deregulated in many cancers, making it difficult to kill tumours. Drugs that restore the normal apoptotic pathways have the potential for effectively treating cancers that depend on aberrations of the apoptotic pathway to stay alive. Apoptosis targets that are currently being...

  • From receptors to stress-activated MAP kinases. Ichijo, Hidenori // Oncogene;11/1/99 Review, Vol. 18 Issue 45, p6087 

    The cell signaling pathways that culminate in activation of a family of stress-activated MAP kinases are beginning to be defined. Determination of cell life and cell death is known to largely depend on the balance of intrinsic life and death signals within cells. Recently, two representative...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics